(Q41542207)

2 October 2017

title

Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid (English)

1 reference

2 October 2017

0 references

0 references

0 references

0 references

3

Asberg M

1 reference

2 October 2017

E. Rydin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6183703

23 August 2023

D. Schalling

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6183703

23 August 2023

M. Asberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6183703

23 August 2023

language of work or name

English

0 references

publication date

1 October 1982

1 reference

full work available at URL

2 October 2017

https://api.elsevier.com/content/article/PII:016517819290096L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

https://api.elsevier.com/content/article/PII:016517819290096L?httpAccept=text/plain

23 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

23 August 2023

1 reference

2 October 2017

volume

7

1 reference

2 October 2017

issue

2

1 reference

2 October 2017

page(s)

229-243

1 reference

Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide

2 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline

23 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

A comprehensive psychopathological rating scale

23 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

23 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

23 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Alcohol and Central Serotonin Metabolism in Man

23 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women

23 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry

23 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

The Validity of Projective Techniques and Their Research and Clinical Contribution

23 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Aggression, suicide, and serotonin: relationships to CSF amine metabolites.

23 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Aggression in humans correlates with cerebrospinal fluid amine metabolites

23 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine

23 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

23 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. II

23 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Relationship between aggression and depression. Epidemiological implications of a hypothesis

23 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

A New Depression Scale Designed to be Sensitive to Change

23 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

The brain serotonergic system in the affective disorders

23 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

CENTRAL SEROTONIN DEFICIENCY-A FACTOR WHICH INCREASES DEPRESSION VULNERABILITY?

23 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

23 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Cerebral monoamines and depression. An investigation with the Probenecid technique.

23 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity

23 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects

23 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

23 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Monoamine metabolites in CSF and suicidal behavior

23 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

Potentiation of the antidepressant action of clomipramine by tryptophan

23 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0165-1781(92)90096-L

23 August 2023

Identifiers

1 reference

2 October 2017

1 reference